<?xml version="1.0" encoding="UTF-8"?>
<ref id="B18-medicines-04-00066" class="ref">
 <label class="label">18.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Amiel</surname>
    <given-names class="given-names">E.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Ofir</surname>
    <given-names class="given-names">R.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Dudai</surname>
    <given-names class="given-names">N.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Soloway</surname>
    <given-names class="given-names">E.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Rabinsky</surname>
    <given-names class="given-names">T.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Rachmilevitch</surname>
    <given-names class="given-names">S.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Î²-Caryophyllene, a compound isolated from the biblical balm of gilead (
   <italic class="italic">Commiphora gileadensis</italic>), is a selective apoptosis inducer for tumor cell lines
  </article-title>
  <source class="source">Evidence-Based Complement. Altern. Med.</source>
  <year class="year">2012</year>
  <volume class="volume">2012</volume>
  <pub-id pub-id-type="doi" class="pub-id">10.1155/2012/872394</pub-id>
  <?supplied-pmid 22567036?>
  <pub-id pub-id-type="pmid" class="pub-id">22567036</pub-id>
 </element-citation>
</ref>
